← All trials
NCT03229876
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 13, 2018
- Primary completion
- Mar 15, 2019
- Completion date
- Dec 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Shanghai Bioray Laboratory Inc.Lead sponsor
- Zhengzhou UniversityCollaborator
- Central South UniversityOverall official - principal investigator
- Central South UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Zhengzhou UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.